Risperdal/Gynecomastia Trial Stopped; Defense Must Produce Study Reanalysis Data

(November 19, 2015, 1:50 PM EST) -- PHILADELPHIA — A Pennsylvania state court Risperdal gynecomastia trial was stopped Nov. 18 to allow defendants Janssen Pharmaceuticals Inc. and Johnson & Johnson time to give the plaintiff data about a clinical study reanalysis, a source told Mealey Publications (Timothy Stange v. Janssen Pharmaceuticals, Inc., et al., No. 130401984, Pa. Comm. Pls., Philadelphia Co.).

On Nov. 17, Judge Kenneth J. Powell Jr. of the Philadelphia Common Pleas Court ordered biostatistician Warren B. Bilker, Ph.D., of the University of Pennsylvania School of Medicine in Philadelphia “to produce...
To view the full article, register now.